Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Beer

Showing results (331-340 of 420) with videos related to

Pageof 42
Sort By:
JACC. Cardiovascular Imaging|January 14, 2014
PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosisAmbros J Beer, Jaroslav Pelisek, Peter Heider, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 27, 2012
First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnosesAlexander Drzezga, Michael Souvatzoglou, Matthias Eiber, et al.
Urologia Internationalis|July 12, 2014
Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomyTobias Maurer, Thomas Horn, Michael Souvatzoglou, et al.
Journal of Personalized Medicine|December 27, 2024
Standardized Response Assessment in Patients with Advanced Cholangiocarcinoma Treated with Personalized TherapyStephan Ursprung, Wolfgang Thaiss, Janina Beha, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findingsMaria Picchio, Uwe Treiber, Ambros J Beer, et al.
Trials|November 1, 2025
Lessons learned from two multicentre randomised controlled trials undertaken in pharmacies in community settings: a retrospective project management analysisChristopher J Byrne, Sarah K Inglis, Andrew Radley, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expressionAmbros J Beer, Roland Haubner, Ingo Wolf, et al.
The Journal of Urology|December 20, 2015
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate CancerTobias Maurer, Jürgen E Gschwend, Isabel Rauscher, et al.
Clinical Nuclear Medicine|June 9, 2016
Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate CancerIsabel Rauscher, Tobias Maurer, Michael Souvatzoglou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2015
Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear causeIsabel Rauscher, Ambros J Beer, Christoph Schaeffeler, et al.
Pageof 42

Showing results (331-340 of 420) with videos related to

Sort By:
Pageof 42
JACC. Cardiovascular Imaging|January 14, 2014
PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosisAmbros J Beer, Jaroslav Pelisek, Peter Heider, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 27, 2012
First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnosesAlexander Drzezga, Michael Souvatzoglou, Matthias Eiber, et al.
Urologia Internationalis|July 12, 2014
Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomyTobias Maurer, Thomas Horn, Michael Souvatzoglou, et al.
Journal of Personalized Medicine|December 27, 2024
Standardized Response Assessment in Patients with Advanced Cholangiocarcinoma Treated with Personalized TherapyStephan Ursprung, Wolfgang Thaiss, Janina Beha, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findingsMaria Picchio, Uwe Treiber, Ambros J Beer, et al.
Trials|November 1, 2025
Lessons learned from two multicentre randomised controlled trials undertaken in pharmacies in community settings: a retrospective project management analysisChristopher J Byrne, Sarah K Inglis, Andrew Radley, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expressionAmbros J Beer, Roland Haubner, Ingo Wolf, et al.
The Journal of Urology|December 20, 2015
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate CancerTobias Maurer, Jürgen E Gschwend, Isabel Rauscher, et al.
Clinical Nuclear Medicine|June 9, 2016
Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate CancerIsabel Rauscher, Tobias Maurer, Michael Souvatzoglou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2015
Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear causeIsabel Rauscher, Ambros J Beer, Christoph Schaeffeler, et al.
Pageof 42